Altitude Crest Partners Inc. Spring Works Therapeutics, Inc. Transaction History
Altitude Crest Partners Inc.
- $234 Billion
- Q1 2024
A detailed history of Altitude Crest Partners Inc. transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Altitude Crest Partners Inc. holds 128,842 shares of SWTX stock, worth $4.85 Million. This represents 2.71% of its overall portfolio holdings.
Number of Shares
128,842Holding current value
$4.85 Million% of portfolio
2.71%Shares
1 transactions
Others Institutions Holding SWTX
# of Institutions
234Shares Held
67.7MCall Options Held
546KPut Options Held
29.4K-
Vanguard Group Inc Valley Forge, PA6.53MShares$246 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.44MShares$205 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.11MShares$155 Million0.02% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.48MShares$131 Million5.66% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$129 Million8.76% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.35B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...